Adjuvant therapy using ex vivo-expanded allogenic natural killer cells in hepatectomy patients with hepatitis B virus related solitary hepatocellular carcinoma: MG4101 study

BACKGROUNDS/AIMS: Fewer reports have been published regarding hepatectomy patients with solitary hepatocellular carcinoma (HCC) who received immunotherapeutic agents as adjuvant therapy. We evaluated the safety and efficacy of ex vivo-expanded allogenic natural killer (NK) cells in those patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jong Man, Cho, Sung Yoo, Rhu, Jinsoo, Jung, Miyoung, Her, Jung Hyun, Lim, Okjae, Choi, Gyu-Seong, Shin, Eui-Cheol, Hwang, Yu-Kyeong, Joh, Jae-Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Hepato-Biliary-Pancreatic Surgery 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180393/
https://www.ncbi.nlm.nih.gov/pubmed/34053923
http://dx.doi.org/10.14701/ahbps.2021.25.2.206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180393/
https://www.ncbi.nlm.nih.gov/pubmed/34053923
http://dx.doi.org/10.14701/ahbps.2021.25.2.206

Ejemplares similares